Locations:

Tag: secondary progressive multiple sclerosis

hand pointing at brain scans on a computer monitoring

April 9, 2025/Neurosciences/Multiple Sclerosis

Disability Progression Slowed for First Time in Nonrelapsing Secondary Progressive Multiple Sclerosis

BTK inhibitor tolebrutinib shows positive results in phase 3 HERCULES trial

middle-aged woman leaning against porch railing

September 20, 2024/Neurosciences/Multiple Sclerosis

First Evidence of Delayed Disability Progression in Nonrelapsing Secondary Progressive Multiple Sclerosis

The BTK inhibitor tolebrutinib meets its primary endpoint in phase 3 HERCULES trial

March 23, 2018/Neurosciences/Research

Disability Progression Slowed for First Time in Large Trial of Secondary Progressive MS

Phase 3 EXPAND trial suggests potential utility of siponimod

BackPage 1 of 1Next

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy